Sysmex ADR Other Non-Current Liabilities 2016-2024 | SSMXY
Sysmex ADR other non-current liabilities from 2016 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- Sysmex ADR other non-current liabilities for the quarter ending December 31, 2024 were $0.078B, a 241.06% increase year-over-year.
- Sysmex ADR other non-current liabilities for 2024 were $0.074B, a 27.98% increase from 2023.
- Sysmex ADR other non-current liabilities for 2023 were $0.057B, a 27.75% decline from 2022.
- Sysmex ADR other non-current liabilities for 2022 were $0.08B, a 99.07% increase from 2021.
| Sysmex ADR Annual Other Non-Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $74 |
| 2023 | $57 |
| 2022 | $80 |
| 2021 | $40 |
| 2020 | $24 |
| 2019 | $31 |
| 2018 | $27 |
| 2017 | $52 |
| 2016 | $32 |
| Sysmex ADR Quarterly Other Non-Current Liabilities (Millions of US $) |
|
|---|---|
| 2024-06-30 | $78 |
| 2023-06-30 | $68 |
| 2022-06-30 | $61 |
| 2021-06-30 | $46 |
| 2020-06-30 | $23 |
| 2019-06-30 | $21 |
| 2018-06-30 | $28 |
| 2017-06-30 | $51 |
| 2016-06-30 | $29 |
| 2016-03-31 | $37 |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $10.505B | $3.340B |
| Sysmex Corporation is engaged in the development, manufacture, import, export and sale of clinical laboratory instruments, reagents and software used in -vitro diagnostics. It also provides clinical laboratory testing of blood, urine and other specimens. The company's product includes instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis and point-of-care testing. Its operating segment consists of Japan, Americas, EMEA, China and Asia Pacific. Sysmex Corporation is headquartered in Kobe, Japan. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $188.546B | 82.58 |
| Thermo Fisher Scientific (TMO) | United States | $162.598B | 19.67 |
| Edwards Lifesciences (EW) | United States | $46.224B | 30.31 |
| Alcon (ALC) | Switzerland | $43.751B | 29.57 |
| IDEXX Laboratories (IDXX) | United States | $43.516B | 50.01 |
| DexCom (DXCM) | United States | $33.510B | 51.79 |
| IQVIA Holdings (IQV) | United States | $28.637B | 16.04 |
| Mettler-Toledo (MTD) | United States | $25.693B | 30.56 |
| STERIS (STE) | Ireland | $22.696B | 25.00 |
| Waters (WAT) | United States | $21.023B | 29.66 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.706B | 0.00 |
| Hologic (HOLX) | United States | $14.897B | 16.19 |
| Penumbra (PEN) | United States | $9.444B | 74.12 |
| Masimo (MASI) | United States | $9.018B | 33.26 |
| Globus Medical (GMED) | United States | $7.825B | 18.65 |
| Glaukos (GKOS) | United States | $6.088B | 0.00 |
| Teleflex (TFX) | United States | $5.300B | 8.75 |
| Integer Holdings (ITGR) | United States | $4.249B | 22.26 |
| TransMedics (TMDX) | United States | $4.221B | 91.75 |
| PROCEPT BioRobotics (PRCT) | United States | $3.276B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.545B | 15.15 |
| Veracyte (VCYT) | United States | $2.155B | 30.24 |
| Nihon Kohden (NHNKY) | Japan | $2.134B | 24.47 |
| Elekta AB (EKTAY) | Sweden | $1.961B | 17.63 |
| Alphatec Holdings (ATEC) | United States | $1.693B | 0.00 |
| Artivion (AORT) | United States | $1.390B | 130.24 |
| Pulse Biosciences (PLSE) | United States | $1.152B | 0.00 |
| OPKO Health (OPK) | United States | $1.079B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.077B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.023B | 5.44 |
| SiBone (SIBN) | United States | $0.800B | 0.00 |
| IRadimed (IRMD) | United States | $0.756B | 38.37 |
| Semler Scientific (SMLR) | United States | $0.629B | 13.64 |
| Beta Bionics (BBNX) | United States | $0.588B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.567B | 8.82 |
| AxoGen (AXGN) | United States | $0.549B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.545B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.493B | 11.55 |
| Pacific Biosciences Of California (PACB) | United States | $0.450B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.445B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.437B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.391B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.385B | 0.00 |
| RxSight (RXST) | United States | $0.344B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.335B | 0.00 |
| NeuroPace (NPCE) | United States | $0.334B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.267B | 0.00 |
| 908 Devices (MASS) | United States | $0.259B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.239B | 14.45 |
| Neuronetics (STIM) | United States | $0.234B | 0.00 |
| Inogen (INGN) | United States | $0.197B | 0.00 |
| CVRx (CVRX) | United States | $0.181B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.177B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.160B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.148B | 0.00 |
| Accuray (ARAY) | United States | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.128B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.120B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.118B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.115B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.096B | 0.00 |
| Spectral AI (MDAI) | United States | $0.078B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.076B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.075B | 45.80 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.063B | 0.00 |
| Hyperfine (HYPR) | United States | $0.061B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.059B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 21.22 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.027B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.023B | 0.00 | |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.69 |